Literature DB >> 6193939

Altered topography of EEG spectral content in schizophrenia.

R Morstyn, F H Duffy, R W McCarley.   

Abstract

EEG data were recorded in resting and in specific test conditions designed to activate different regions of the brain in a group (n = 10) of chronic schizophrenics and matched controls. EEG spectral energy was computed using the Fast Fourier Transform and numerical matrices representing the topographic distribution of spectral energy in a specified band were constructed and displayed as color images. Significance Probability Mapping was employed to identify regions of maximal group difference; it was found that the schizophrenic group showed increased low frequency energy (0-7 c/sec) in the frontal regions and increased fast activity (12-32 c/sec) in post-central areas and the left anterior temporal area. The different psychological test conditions were associated with different patterns of energy distribution. The consistency of our findings with other investigations suggests that topographic mapping of brain EEG spectral activity may play a useful role in the functional understanding of schizophrenia.

Entities:  

Mesh:

Year:  1983        PMID: 6193939     DOI: 10.1016/0013-4694(83)90251-1

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  11 in total

1.  A spatial power spectrum analysis of the electroencephalogram.

Authors:  R B Paranjape; Z J Koles; J Lind
Journal:  Brain Topogr       Date:  1990       Impact factor: 3.020

2.  EEG coherence during hemispheric activation in schizophrenics.

Authors:  S Michelogiannis; N Paritsis; P Trikas
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

Review 3.  Topographic mapping of EEG and evoked potentials in psychiatry: delusions, illusions, and realities.

Authors:  M W Torello
Journal:  Brain Topogr       Date:  1989       Impact factor: 3.020

4.  Brain imaging: evoked potential, quantitative EEG and SPECT abnormalities in schizophrenia.

Authors:  K G Sieg; D A Willsie; D F Preston; G R Gaffney
Journal:  J Psychiatry Neurosci       Date:  1991-03       Impact factor: 6.186

Review 5.  Patterns of spontaneous magnetoencephalographic activity in patients with schizophrenia.

Authors:  Peter J Siekmeier; Steven M Stufflebeam
Journal:  J Clin Neurophysiol       Date:  2010-06       Impact factor: 2.177

6.  The effects of dexamphetamine on the resting-state electroencephalogram and functional connectivity.

Authors:  Matthew A Albrecht; Gareth Roberts; Greg Price; Joseph Lee; Rajan Iyyalol; Mathew T Martin-Iverson
Journal:  Hum Brain Mapp       Date:  2015-11-18       Impact factor: 5.038

7.  EEG reactivity and EEG activity in never-treated acute schizophrenics, measured with spectral parameters and dimensional complexity.

Authors:  M Koukkou; D Lehmann; A Federspiel; M C Merlo
Journal:  J Neural Transm Gen Sect       Date:  1995

8.  Hypofrontality on topographic EEG in schizophrenia. Correlations with neuropsychological and psychopathological parameters.

Authors:  W F Gattaz; S Mayer; P Ziegler; M Platz; T Gasser
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

9.  Early auditory processing evoked potentials (N100) show a continuum of blunting from clinical high risk to psychosis in a pediatric sample.

Authors:  Joseph Gonzalez-Heydrich; Michelle Bosquet Enlow; Eugene D'Angelo; Larry J Seidman; Sarah Gumlak; April Kim; Kristen A Woodberry; Ashley Rober; Sahil Tembulkar; Kelsey Graber; Kyle O'Donnell; Hesham M Hamoda; Kara Kimball; Alexander Rotenberg; Lindsay M Oberman; Alvaro Pascual-Leone; Matcheri S Keshavan; Frank H Duffy
Journal:  Schizophr Res       Date:  2015-11-06       Impact factor: 4.939

10.  Effect of music listening on P300 event-related potential in patients with schizophrenia: A pilot study.

Authors:  Shikha Ahuja; Rajnish Kumar Gupta; Dinakaran Damodharan; Mariamma Philip; Ganesan Venkatasubramanian; Matcheri S Keshavan; Shantala Hegde
Journal:  Schizophr Res       Date:  2020-01-07       Impact factor: 4.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.